Israeli drug company Kamada reports that on recent clinical trials done with its Glassia drug, results have shown positive results for treating lung disease. Laboratory mice with bacterial lung infection have shown significant improvement once treated with the drug.
Related posts
A Promising Treatment For Trauma-Induced Fibromyalgia
March 23, 2023
Generative AI Startup Helps Developers Test Code Logic
March 23, 2023
Cream Cheese And Cheddar Cheese – Made From Chickpeas
March 22, 2023
$8M For Startup That Digitizes The Construction Supply Chain
March 22, 2023
Facebook comments